Real-World Diagnostic Performance of RSNA Consensus Reporting Guidelines for Findings Related to COVID-19 on Chest CT.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 34346787.
- Also identified by DOI 10.2214/AJR.21.26560.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study evaluated the real-world diagnostic performance of Radiological Society of North America COVID-19 consensus reporting guidelines among 2618 chest CT reports from the author's health care network from April 2020 through March 2021; reverse-transcriptase polymerase chain reaction served as the reference. Typical findings exhibited sensitivity of 68% and specificity of 91%, similar to performance reported in research settings. PPV of 52% was lower than previously reported, attributed to low COVID-19 prevalence. Accuracy improved from 84% in April 2020 to 92% in March 2021 (<i>p</i> = .03).
Medical subject headings
- COVID-19
- Lung
- SARS-CoV-2
- Tomography, X-Ray Computed